Crispr Therapeutics shares owned by Thrivent Financial for Lutherans
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Thrivent Financial for Lutherans
from 13F filings
Historical chart of Thrivent Financial for Lutherans investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Thrivent Financial for Lutherans consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Thrivent Financial for Lutherans
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $2.1M | 31k | 68.17 |
| 2023-09-30 | $1.5M | 34k | 45.40 |
| 2023-06-30 | $2.7M | 49k | 56.07 |
| 2023-03-31 | $2.2M | 49k | 45.20 |
| 2022-12-31 | $3.2M | 79k | 40.66 |
| 2022-09-30 | $1.6M | 25k | 65.45 |
| 2022-06-30 | $1.3M | 21k | 60.77 |
| 2022-03-31 | $733k | 12k | 62.75 |
| 2021-12-31 | $3.1M | 40k | 75.77 |
| 2021-09-30 | $209k | 1.9k | 111.88 |
| 2021-06-30 | $640k | 4.0k | 161.85 |
| 2021-03-31 | $315k | 2.6k | 121.95 |
| 2020-12-31 | $247k | 1.6k | 153.32 |
More positions owned by Thrivent Financial for Lutherans
View all positions for Thrivent Financial for Lutherans